The Global Mitral Valve (Stenosis & Regurgitation) Treatment Market is projected to reach USD 16,499.08 million by 2030, expanding at a CAGR of 8.48% during the 2025–2035 forecast period. The two most common forms of mitral valve disease are mitral stenosis, where the valve becomes narrowed, and mitral regurgitation, where it fails to close properly and allows blood to leak backward.
Growing Patient Preference for Minimally Invasive Procedures
A strong shift toward patient-centric care is driving demand for minimally invasive and non-sternotomy treatments in mitral valve disease management. In fact, about 90% of patients who are eligible for this type of treatment prefer to have their valve repaired rather than replaced. And the reason behind this is repairing the valve can lead to better long-term results and help keep the heart functioning properly.
Detailed Segment Breakdown
Pathological Condition
• Mitral Stenosis: Constricted valve limits atrial-ventricular blood flow.
• Mitral Regurgitation: Valve dysfunction causes backward blood movement.
Etiology (Stenosis)
• Rheumatic Mitral Stenosis: Rheumatic disease scars and narrows valve.
• Calcified (Non-Rheumatic) Mitral Stenosis: Calcium buildup restricts valve mobility.
Treatment (Stenosis)
• Stenosis Medications: Medicines control symptoms and prevent complications.
• Mitral Valve Repair Surgery: Repair maintains native valve structure.
• Mitral Valve Replacement Surgery: Replacement ensures restored valve functionality.
• Transcatheter Balloon Valvotomy: Balloon catheter widens stenotic mitral valve.
• Transcatheter Mitral Valve Repair & Replacement: Catheter-based valve repair and replacement solutions.
Etiology (Regurgitation)
• Calcified Mitral Regurgitation (MAC): Calcified annulus leads to valve leakage.
• Non-Calcified Mitral Regurgitation: Valve leaflet abnormalities cause regurgitation.
Treatment (Regurgitation)
• Regurgitation Medications: Drug therapy stabilizes heart and symptoms.
• Repair Surgery for Regurgitation: Surgical correction improves valve performance.
• Replacement Surgery for Regurgitation: Valve prosthesis resolves severe regurgitation.
• Balloon Valvotomy for Regurgitation: Interventional balloon technique enhances valve opening.
• Transcatheter Repair/Replacement for Regurgitation: Minimally invasive treatment for advanced regurgitation.
Regional Market Overview
Some regions, like North America and Europe, are ahead of the curve when it comes to treating mitral valve disease. They have good healthcare systems, a large older population, and are quick to adopt new, less invasive technologies. On the other hand, Asia, South America, and the Middle East are just starting to catch up. They're improving their healthcare systems, and more people are getting access to advanced treatments.
Breakthrough Data for Minimally Invasive Mitral Valve Therapy
Medtronic, recently shared some promising results about its Intrepid TMVR system. This system is a type of minimally invasive treatment for mitral valve disease. The results showed that patients who used this system had good long-term outcomes, with stable valves, minimal leakage, and improved heart function. This is exciting news for people with mitral valve disease, as it could mean a new, effective treatment option.
Rising Disease Burden Driving Treatment Demand
Mitral valve disorders, like stenosis and regurgitation, are becoming more common and are contributing to heart problems worldwide. These conditions can restrict blood flow in the heart, leading to symptoms like fatigue, shortness of breath, and even severe heart failure if left untreated. It's essential to diagnose and treat these conditions quickly to prevent complications.
Key Report Attributes
• Market Size 2024: USD 6,750.71 Million
• Market Size 2030: USD 16,499.08 Million
• CAGR (2025-2035): 8.48%
• Base Year: 2024
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Pathological Condition: Mitral Stenosis - 5.61%, Mitral Regurgitation - 8.83%.
• By Etiology (Stenosis): Rheumatic Mitral Stenosis - 5.15%, Calcified (Non-Rheumatic) Mitral Stenosis - 5.79%.
• By Treatment (Stenosis): Medications - 5.02%, Surgery - 6.12%.
• By Etiology (Regurgitation): Calcified Mitral Regurgitation (Including Mitral Annular Calcification MAC) - 9.15%, Non-Calcified Mitral Regurgitation - 8.60%.
• By Treatment (Regurgitation): Medications - 8.18%, Surgery - 9.41%.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 2 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 3 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, FOR MITRAL STENOSIS, BY REGION, 2019–2035 (USD MILLION)
TABLE 4 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, FOR MITRAL REGURGITATION, BY REGION, 2019–2035 (USD MILLION)
TABLE 5 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 6 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 7 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR RHEUMATIC MITRAL STENOSIS, BY REGION, 2019–2035 (USD MILLION)
TABLE 8 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR CALCIFIED (NON-RHEUMATIC) MITRAL STENOSIS, BY REGION, 2019 -2035 (USD MILLION)
TABLE 9 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 10 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 11 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR MEDICATIONS, BY REGION, 2019–2035 (USD MILLION)
TABLE 12 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY REGION, 2019–2035 (USD MILLION)
TABLE 13 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, BY REGION, 2019–2035 (USD MILLION)
TABLE 14 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, BY REGION, 2019–2035 (VOLUME IN UNITS) 43
TABLE 15 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR MITRAL VALVE REPAIR SURGERY, BY REGION, 2019–2035 (USD MILLION)
TABLE 16 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR MITRAL VALVE REPLACEMENT SURGERY, BY REGION, 2019–2035 (USD MILLION)
TABLE 17 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR TRANSCATHETER BALLOON VALVOTOMY, BY REGION, 2019–2035 (USD MILLION)
TABLE 18 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, FOR TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT, BY REGION, 2019–2035 (USD MILLION)
TABLE 19 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 20 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 21 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR CALCIFIED MITRAL REGURGITATION (INCLUDING MITRALANNULAR CALCIFICATION MAC), BY REGION, 2019–2035 (USD MILLION)
TABLE 22 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR NON-CALCIFIED MITRAL REGURGITATION, BY REGION, 2019-2035 (USD MILLION)
TABLE 23 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 24 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 25 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR MEDICATIONS, BY REGION, 2019–2035 (USD MILLION) 54
TABLE 26 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY REGION, 2019–2035 (USD MILLION)
TABLE 27 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, BY REGION, 2019–2035 (USD MILLION)
TABLE 28 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, BY REGION, 2019–2035 (VOLUME IN UNITS)
TABLE 29 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR MITRAL VALVE REPAIR SURGERY, BY REGION, 2019–2035 (USD MILLION)
TABLE 30 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR MITRAL VALVE REPLACEMENT SURGERY, BY REGION, 2019-2035 (USD MILLION)
TABLE 31 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR TRANSCATHETER BALLOON VALVOTOMY, BY REGION, 2019-2035 (USD MILLION)
TABLE 32 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT, BY REGION, 2019–2035 (USD MILLION)
TABLE 1 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY REGION, 2019–2035 (USD MILLION)
TABLE 2 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY REGION, 2019–2035 (VOLUME IN UNITS)
TABLE 3 NORTH AMERICA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION)
TABLE 4 NORTH AMERICA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION)
TABLE 5 NORTH AMERICA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 6 NORTH AMERICA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 7 NORTH AMERICA: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 8 NORTH AMERICA: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 9 NORTH AMERICA: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 10 NORTH AMERICA: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 11 NORTH AMERICA: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 12 NORTH AMERICA: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 13 NORTH AMERICA: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 14 NORTH AMERICA: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 15 NORTH AMERICA: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 16 NORTH AMERICA: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 17 NORTH AMERICA: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 71
TABLE 18 US: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 19 US: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 20 US: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 21 US: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 22 US: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 23 US: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 24 US: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 25 US: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 26 US: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 27 US: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 28 US: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 29 US: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 30 US: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 31 US: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 32 CANADA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 33 CANADA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 34 CANADA: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 36 CANADA: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 80
TABLE 37 CANADA: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 80
TABLE 38 CANADA: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 80
TABLE 39 CANADA: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 81
TABLE 40 CANADA: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 81
TABLE 41 CANADA: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 82
TABLE 42 CANADA: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 82
TABLE 43 CANADA: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 83
TABLE 44 CANADA: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 83
TABLE 45 CANADA: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 84
TABLE 46 CANADA: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 84
TABLE 47 EUROPE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 87
TABLE 48 EUROPE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 88
TABLE 49 EUROPE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD
MILLION) 89
TABLE 50 EUROPE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN
UNITS) 89
TABLE 51 EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 90
TABLE 52 EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 90
TABLE 53 EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 90
TABLE 54 EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 91
TABLE 55 EUROPE: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 91
TABLE 56 EUROPE: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 92
TABLE 57 EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 92
TABLE 58 EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 93
TABLE 59 EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 93
TABLE 60 EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 93
TABLE 61 EUROPE: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 94
TABLE 62 EUROPE: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 94
TABLE 63 GERMANY: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD
MILLION) 95
TABLE 64 GERMANY: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME
IN UNITS) 95
TABLE 65 GERMANY: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 96
TABLE 66 GERMANY: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 96
TABLE 67 GERMANY: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 96
TABLE 68 GERMANY: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 97
TABLE 69 GERMANY: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 97
TABLE 70 GERMANY: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 98
TABLE 71 GERMANY: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 98
TABLE 72 GERMANY: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 99
TABLE 73 GERMANY: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 99
TABLE 74 GERMANY MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 99
TABLE 75 GERMANY: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 100
TABLE 76 GERMANY: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 100
TABLE 77 FRANCE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 78 FRANCE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 79 FRANCE: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 80 FRANCE: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 81 FRANCE: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 82 FRANCE: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 83 FRANCE: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 84 FRANCE: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 85 FRANCE: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 86 FRANCE: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 87 FRANCE: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 88 FRANCE: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 89 FRANCE: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 90 UK: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 91 UK: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 92 UK: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 93 UK: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 94 UK: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 95 UK: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 96 UK: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 97 UK: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 98 UK: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 100 UK: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 101 UK: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 102 UK: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 103 UK: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 104 UK: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 105 ITALY: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 106 ITALY: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 107 ITALY: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 108 ITALY: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 109 ITALY: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 110 ITALY: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 111 ITALY: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 112 ITALY: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 113 ITALY: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 114 ITALY: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 115 ITALY: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 116 ITALY: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 117 ITALY: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 119
TABLE 118 ITALY: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 119
TABLE 119 SPAIN: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD
MILLION) 120
TABLE 120 SPAIN: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS) 120
TABLE 121 SPAIN: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 121
TABLE 122 SPAIN: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 121
TABLE 123 SPAIN: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 121
TABLE 124 SPAIN: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 122
TABLE 125 SPAIN: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 122
TABLE 126 SPAIN: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 123
TABLE 127 SPAIN: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 123
TABLE 128 SPAIN: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 124
TABLE 129 SPAIN: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 124
TABLE 130 SPAIN: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 124
TABLE 131 SPAIN: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 125
TABLE 132 SPAIN: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 125
TABLE 133 RUSSIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (USD
MILLION) 126
TABLE 134 RUSSIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN
UNITS) 126
TABLE 135 RUSSIA: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 127
TABLE 136 RUSSIA: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 127
TABLE 137 RUSSIA: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 127
TABLE 138 RUSSIA: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 128
TABLE 139 RUSSIA: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 128
TABLE 140 RUSSIA: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 129
TABLE 141 RUSSIA: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 129
TABLE 142 RUSSIA: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 130
TABLE 143 RUSSIA: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 130
TABLE 144 RUSSIA: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 130
TABLE 145 RUSSIA: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 131
TABLE 146 RUSSIA: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 131
TABLE 147 REST OF EUROPE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035
(USD MILLION) 132
TABLE 148 REST OF EUROPE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, PATHOLOGICAL CONDITION, 2019–2035
(VOLUME IN UNITS) 132
TABLE 149 REST OF EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 133
TABLE 150 REST OF EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 133
TABLE 151 REST OF EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 134
TABLE 152 REST OF EUROPE: MITRAL STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 134
TABLE 153 REST OF EUROPE: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 135
TABLE 154 REST OF EUROPE: MITRAL STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 135
TABLE 155 REST OF EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 136
TABLE 156 REST OF EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 136
TABLE 157 REST OF EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 137
TABLE 158 REST OF EUROPE: MITRAL REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 137
TABLE 159 REST OF EUROPE: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 138
TABLE 160 REST OF EUROPE: MITRAL REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 138
TABLE 161 ASIA-PACIFIC: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 141
TABLE 162 ASIA-PACIFIC: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2019–2035 (VOLUME IN UNITS)
TABLE 163 ASIA-PACIFIC: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION) 143
TABLE 164 ASIA-PACIFIC: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS) 143
TABLE 165 ASIA-PACIFIC: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 143
TABLE 166 ASIA-PACIFIC: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 144
TABLE 167 ASIA-PACIFIC: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 144
TABLE 168 ASIA-PACIFIC: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 144
TABLE 169 ASIA-PACIFIC: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 145
TABLE 170 ASIA-PACIFIC: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 145
TABLE 171 ASIA-PACIFIC: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 146
TABLE 172 ASIA-PACIFIC: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 146
TABLE 173 ASIA-PACIFIC: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 147
TABLE 174 ASIA-PACIFIC: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 147
TABLE 175 ASIA-PACIFIC: MITRAL VALVE REGURGITATIONTREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 147
TABLE 176 ASIA-PACIFIC: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 148
TABLE 177 CHINA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION) 148
TABLE 178 CHINA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS) 149
TABLE 179 CHINA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 149
TABLE 180 CHINA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 149
TABLE 181 CHINA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 150
TABLE 182 CHINA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 150
TABLE 183 CHINA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 150
TABLE 184 CHINA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 151
TABLE 185 CHINA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 151
TABLE 186 CHINA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 152
TABLE 187 CHINA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 152
TABLE 188 CHINA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS) 152
TABLE 189 CHINA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION) 153
TABLE 190 CHINA: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 153
TABLE 191 INDIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD
MILLION) 154
TABLE 192 INDIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME
IN UNITS) 154
TABLE 193 INDIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION) 154
TABLE 194 INDIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS) 155
TABLE 195 INDIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION) 155
TABLE 196 INDIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 197 INDIA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 198 INDIA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 199 INDIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 200 INDIA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 201 INDIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 202 INDIA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 203 INDIA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 204 INDIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 205 JAPAN: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 206 JAPAN: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 207 JAPAN: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 208 JAPAN: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 209 JAPAN: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 210 JAPAN: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 211 JAPAN: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 212 JAPAN: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 213 JAPAN: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 214 JAPAN: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 215 JAPAN: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 216 JAPAN: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 217 JAPAN: MITRAL VALVE REGURGITATIONTREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 218 JAPAN: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 219 SOUTH KOREA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 220 SOUTH KOREA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 221 SOUTH KOREA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 222 SOUTH KOREA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 223 SOUTH KOREA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 224 SOUTH KOREA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 225 SOUTH KOREA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 226 SOUTH KOREA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 227 SOUTH KOREA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 228 SOUTH KOREA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 229 SOUTH KOREA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 230 SOUTH KOREA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 231 SOUTH KOREA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 232 SOUTH KOREA: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)170
TABLE 233 MALAYSIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION) 170
TABLE 234 MALAYSIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS) 171
TABLE 235 MALAYSIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 236 MALAYSIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 237 MALAYSIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 238 MALAYSIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 239 MALAYSIA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 240 MALAYSIA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 241 MALAYSIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 242 MALAYSIA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 243 MALAYSIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 244 MALAYSIA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 245 MALAYSIA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 246 MALAYSIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 175
TABLE 247 THAILAND: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION) 176
TABLE 248 THAILAND: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 249 THAILAND: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 250 THAILAND: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 251 THAILAND: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 252 THAILAND: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 253 THAILAND: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 254 THAILAND: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 255 THAILAND: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 256 THAILAND: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 257 THAILAND: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 258 THAILAND: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 259 THAILAND: MITRAL VALVE REGURGITATIONTREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 260 THAILAND: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 181
TABLE 261 INDONESIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (USD MILLION)
TABLE 262 INDONESIA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2019–2035 (VOLUME IN UNITS)
TABLE 263 INDONESIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 264 INDONESIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
TABLE 274 INDONESIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS) 187
TABLE 265 INDONESIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (USD MILLION)
TABLE 266 INDONESIA: MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2019–2035 (VOLUME IN UNITS)
TABLE 267 INDONESIA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (USD MILLION)
TABLE 268 INDONESIA: MITRAL VALVE STENOSIS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019–2035 (VOLUME IN UNITS)
TABLE 269 INDONESIA: MITRAL VALVE REGURGITATION TREATMENT MARKET, BY ETIOLOGY, 2019–2035 (USD MILLION)
TABLE 270 INDONESIA: MITRAL VALVE REGURGITATIONTREATMENT MARKET, BY ETIOLOGY, 2019–2035 (VOLUME IN UNITS)
LIST OF FIGURES
FIGURE 1 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET: STRUCTURE
FIGURE 2 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, SOFTWARE TYPE SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 3 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY PATHOLOGICAL CONDITION, 2024 & 2035 (USD MILLION)
FIGURE 4 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKETSHARE (%), BY TYPE, 2024
FIGURE 5 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, APPLICATION SEGMENT, 2024 & 2035 (USD MILLION)
FIGURE 6 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, BY ETIOLOGY, 2024 & 2035 (USD MILLION)
FIGURE 7 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET SHARE (%), BY APPLICATION, 2024
FIGURE 8 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, TREATMENT SEGMENT, 2024 & 2035 (USD MILLION)
FIGURE 9 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, FOR SURGERY, SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 40
FIGURE 10 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, BY TREATMENT, 2024 & 2035 (USD MILLION)
FIGURE 11 GLOBAL MITRAL VALVE STENOSIS TREATMENT MARKET, SHARE (%), BY TREATMENT, 2024
FIGURE 12 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, ETIOLOGY SEGMENT, 2024 & 2035 (USD MILLION)
FIGURE 13 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET SHARE (%), BY ETIOLOGY, 2024 & 2035 (USD MILLION)
FIGURE 14 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET SHARE (%), BY ETIOLOGY, 2024
FIGURE 15 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, TREATMENT SEGMENT, 2024 & 2035 (USD MILLION)
FIGURE 16 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, FOR SURGERY, SEGMENT ATTRACTIVENESS, 2024
& 2035 (USD MILLION)
52
FIGURE 17 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, BY TREATMENT, 2024 & 2035 (USD MILLION)
FIGURE 18 GLOBAL MITRAL VALVE REGURGITATION TREATMENT MARKET, SHARE (%), BY TREATMENT, 2024
FIGURE 19 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY REGION, 2024 & 2035 (USD MILLION)
FIGURE 20 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET SHARE (%), BY REGION, 2024
FIGURE 21 NORTH AMERICA MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 62
FIGURE 22 NORTH AMERICA MARKET ANALYSIS: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, 2019-2033 (USD MILLION)
FIGURE 23 NORTH AMERICA: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 24 EUROPE MARKET ANALYSIS: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, 2019-2033 (USD MILLION) 86
FIGURE 25 EUROPE MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 87
FIGURE 26 EUROPE: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET SHARE (%), BY COUNTRY, 2024 88
FIGURE 27 ASIA-PACIFIC MARKET ANALYSIS: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, 2019-2035 (USD MILLION)140
FIGURE 28 ASIA-PACIFIC: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
FIGURE 29 ASIA-PACIFIC: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET SHARE, BY COUNTRY, 2024 (%)
FIGURE 30 SOUTH AMERICA MARKET ANALYSIS: MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET, 2019-2035 (USD MILLION)
FIGURE 31 SOUTH AMERICA MITRAL VALVE REGURGITATION TREATMENT MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION)
FIGURE 32 SOUTH AMERICA MITRAL VALVE REGURGITATION TREATMENT MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 33 MIDDLE EAST & AFRICA MARKET ANALYSIS: MITRAL VALVE REGURGITATION TREATMENT MARKET, 2019-2035 (USD MILLION) 227
FIGURE 34 MIDDLE EAST & AFRICA MITRAL VALVE REGURGITATION TREATMENT MARKET, BY REGION, 2024 & 2035 (USD MILLION)
FIGURE 35 MIDDLE EAST & AFRICA MITRAL VALVE REGURGITATION TREATMENT MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 36 GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 253
FIGURE 37 COMPETITOR DASHBOARD: GLOBAL MITRAL VALVE (STENOSIS & REGURGITATION) TREATMENT MARKET 254
FIGURE 38 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 261
FIGURE 39 MEDTRONIC: SWOT ANALYSIS 263
FIGURE 40 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 265
FIGURE 41 NOVARTIS AG: SWOT ANALYSIS 267
FIGURE 42 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT 269
FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 271
FIGURE 44 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 279
FIGURE 45 ABBOTT: SWOT ANALYSIS 281
FIGURE 46 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 284
FIGURE 47 BAYER AG: SWOT ANALYSIS 285
FIGURE 48 EDWARDS LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 288
FIGURE 49 ARTIVION, INC.: FINANCIAL OVERVIEW SNAPSHOT 292
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們